Back to top
more

Apyx Medical (APYX)

(Real Time Quote from BATS)

$1.49 USD

1.49
44,003

-0.01 (-0.67%)

Updated May 13, 2024 11:53 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value C Growth F Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 40% (100 out of 251)

Industry: Medical - Products

Better trading starts here.

Zacks News

Agios Gets Orphan Drug Tag for Mitapivat to Treat Thalassemia

The FDA confers an orphan drug status on Agios' (AGIO) pyruvate kinase-R activator mitapivat for addressing patients with thalassemia. Stock rises in after-hours trading.

Why Apyx (APYX) Stock Might be a Great Pick

Apyx (APYX) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.

Canopy Growth (CGC) in Focus: Stock Moves 6.4% Higher

Canopy Growth (CGC) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.

Will Apyx Medical Continue to Surge Higher?

As of late, it has definitely been a great time to be an investor of Apyx Medical

Quidel (QDEL) in Focus: Stock Moves 6.2% Higher

Quidel (QDEL) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.

PetIQ (PETQ) Catches Eye: Stock Jumps 8.4%

PetIQ (PETQ) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.

Apyx Medical (APYX) Reports Q1 Loss, Misses Revenue Estimates

Apyx (APYX) delivered earnings and revenue surprises of 72.73% and -5.54%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Apyx (APYX) Upgraded to Strong Buy: Here's Why

Apyx (APYX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Top Ranked Momentum Stocks to Buy for November 21st

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, November 21st

Will Apyx Medical Continue to Surge Higher?

As of late, it has definitely been a great time to be an investor Apyx Medical.

Apyx (APYX) Upgraded to Buy: Here's Why

Apyx (APYX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Apyx Medical (APYX) Reports Q3 Loss, Tops Revenue Estimates

Apyx (APYX) delivered earnings and revenue surprises of 27.78% and 13.23%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: Apyx Medical (APYX) Q3 Earnings Expected to Decline

Apyx (APYX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

What Makes Apyx (APYX) a New Buy Stock

Apyx (APYX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Apyx Medical (APYX) Reports Q2 Loss, Tops Revenue Estimates

Apyx (APYX) delivered earnings and revenue surprises of 27.78% and 7.67%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: Apyx Medical (APYX) Q2 Earnings Expected to Decline

Apyx (APYX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Apyx Medical (APYX) to Report Q1 Earnings: What's in Store?

Apyx Medical (APYX) likely to gain from J-plasma technology in Q1; margins under pressure.

Apyx Medical (APYX) Stock Sinks As Market Gains: What You Should Know

In the latest trading session, Apyx Medical (APYX) closed at $6.31, marking a -0.63% move from the previous day.

Apyx Medical (APYX) Stock Sinks As Market Gains: What You Should Know

In the latest trading session, Apyx Medical (APYX) closed at $7.78, marking a -0.51% move from the previous day.

Apyx Medical (APYX) Reports Q4 Loss, Lags Revenue Estimates

Apyx (APYX) delivered earnings and revenue surprises of 0.00% and -1.07%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?

Conatus' (CNAT) Q4 Earnings Top Estimates, Emricasan in Focus

Conatus (CNAT) makes an improvement with narrower-than-expected loss in the fourth quarter of 2018. Also, revenues beat mark.

Zimmer Biomet (ZBH) Jumps: Stock Rises 6.4%

Zimmer Biomet (ZBH) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.

Has Bovie Medical (APYX) Outpaced Other Medical Stocks This Year?

Is (APYX) Outperforming Other Medical Stocks This Year?

Bovie Medical (APYX) is a Great Momentum Stock: Should You Buy?

Does Bovie Medical (APYX) have what it takes to be a top stock pick for momentum investors? Let's find out.